ADRENERGIC RECEPTORS IN VEINS OF DOG

被引:134
作者
GUIMARAES, S
OSSWALD, W
机构
[1] Department of Pharmacology, Medical Faculty University of Porto
关键词
Adrenergic blocking drugs; Catecholamines; Venous reactivity;
D O I
10.1016/0014-2999(69)90021-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The actions of catecholamines and adrenergic blocking drugs on the veins of the dog (posterior vena cava, portal vein, femoral vein, lateral saphenous vein) were studied in vitro. In these experiments quantitative and qualitative differences were found. Superficial veins were more sensitive. Adrenaline and dopamine had direct actions causing contractions blocked by phenoxybenzamine (pM50-6.40) and erotamine (pA2-8.20). Isoprenaline caused relaxation and/or contraction depending on the vein, tone and dose; relaxation was blocked by pronethalol (pA2-6.51) and contractions were antagonized or reversed by ergotamine and phenoxybenzamine. Evidence for the existence of both alpha and beta receptors in the veins, the former prevailing, is presented. Ergotamine induced marked venoconstriction, at least in part through alpha receptor activation; no evidence for a beta blocking action of ergotamine was found. The results in vivo (autoperfused femoral vein, vena cava, and small veins of the paw) correlate well with those found in vitro. Agonists and antagonists exerted effects which can be attributed to the presence of alpha and beta adrenergic receptors. However, in these experiments isoprenaline never caused activation of alpha receptors, probably because the doses used were much lower than those used in vitro. © 1969.
引用
收藏
页码:133 / +
页数:1
相关论文
共 33 条
[1]  
ALEXANDER RS, 1963, HANDBOOK PHYSIOLOG 2, V2, P1075
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]  
BALZER H, 1956, N-S ARCH EX PATH PH, V227, P547
[4]   COMPARISON OF SOME PROPERTIES OF PRONETHALOL AND PROPRANOLOL [J].
BLACK, JW ;
DUNCAN, WAM ;
SHANKS, RG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1965, 25 (03) :577-+
[5]  
BURN JH, 1960, ADRENERGIC MECHANISM, P502
[6]  
CLEMENT D, 1967, ARCH INT PHARMACOD T, V166, P181
[7]  
FLUCKIGE.E, 1967, ARZNEI-FORSCHUNG, V17, P6
[8]  
FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129
[9]  
GUIMARAES S, 1968, RECEPTORES ADRENERGI
[10]   RECEPTORS FOR NORADRENALINE AND HISTAMINE IN RABBITS POSTERIOR VENA CAVA [J].
GULATI, OD ;
PARIKH, HM ;
UMAR, MS .
BRITISH JOURNAL OF PHARMACOLOGY, 1968, 32 (01) :87-&